Latest Insider Transactions at Karyopharm Therapeutics Inc. (KPTI)
This section provides a real-time view of insider transactions for Karyopharm Therapeutics Inc. (KPTI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Karyopharm Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Karyopharm Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 06
2025
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
4,055
-0.36%
|
$0
$0.78 P/Share
|
|
Dec 04
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,620
-0.32%
|
$0
$0.81 P/Share
|
|
Nov 05
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,675
-0.32%
|
$0
$0.91 P/Share
|
|
Oct 04
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,607
-0.32%
|
$0
$0.88 P/Share
|
|
Sep 04
2024
|
Michael Mano SVP, General Counsel&Secretary |
SELL
Open market or private sale
|
Direct |
3,971
-1.43%
|
$0
$0.72 P/Share
|
|
Sep 04
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,667
-0.32%
|
$0
$0.72 P/Share
|
|
Sep 04
2024
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
7,050
-1.77%
|
$0
$0.72 P/Share
|
|
Sep 04
2024
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,356
-1.31%
|
$0
$0.72 P/Share
|
|
Aug 06
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,608
-0.31%
|
$0
$0.93 P/Share
|
|
Jul 30
2024
|
Stuart Poulton EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,883
-0.87%
|
$2,883
$1.06 P/Share
|
|
Jul 05
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,616
-0.31%
|
$0
$0.85 P/Share
|
|
Jun 07
2024
|
Deepika Pakianathan |
SELL
Open market or private sale
|
Indirect |
231,548
-100.0%
|
$0
$0.95 P/Share
|
|
Jun 06
2024
|
Deepika Pakianathan |
SELL
Open market or private sale
|
Indirect |
118,452
-33.83%
|
$0
$0.98 P/Share
|
|
Jun 05
2024
|
Deepika Pakianathan |
SELL
Open market or private sale
|
Indirect |
468,044
-57.21%
|
$0
$0.96 P/Share
|
|
Jun 04
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,592
-0.31%
|
$0
$0.99 P/Share
|
|
Jun 04
2024
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
652
-0.16%
|
$0
$0.99 P/Share
|
|
Jun 04
2024
|
Deepika Pakianathan |
SELL
Open market or private sale
|
Indirect |
341,040
-29.42%
|
$0
$0.95 P/Share
|
|
Jun 03
2024
|
Deepika Pakianathan |
SELL
Open market or private sale
|
Indirect |
360,744
-23.73%
|
$360,744
$1.0 P/Share
|
|
May 31
2024
|
Deepika Pakianathan |
SELL
Open market or private sale
|
Indirect |
204,394
-11.85%
|
$0
$0.95 P/Share
|
|
May 06
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,576
-0.31%
|
$3,576
$1.13 P/Share
|
|
Apr 22
2024
|
Reshma Rangwala EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
6,789
-1.94%
|
$6,789
$1.17 P/Share
|
|
Apr 04
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,563
-0.31%
|
$3,563
$1.29 P/Share
|
|
Mar 05
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
3,573
-0.31%
|
$3,573
$1.3 P/Share
|
|
Mar 01
2024
|
Stuart Poulton EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
6,155
-1.83%
|
$6,155
$1.2 P/Share
|
|
Mar 01
2024
|
Reshma Rangwala EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,969
-1.68%
|
$5,969
$1.2 P/Share
|
|
Mar 01
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
19,374
-1.64%
|
$19,374
$1.2 P/Share
|
|
Mar 01
2024
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
5,109
-1.28%
|
$5,109
$1.2 P/Share
|
|
Mar 01
2024
|
Michael Mano SVP, General Counsel&Secretary |
SELL
Open market or private sale
|
Direct |
3,576
-1.27%
|
$3,576
$1.2 P/Share
|
|
Mar 01
2024
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
6,162
-1.52%
|
$6,162
$1.2 P/Share
|
|
Feb 29
2024
|
Stuart Poulton EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
16,311
-4.63%
|
$16,311
$1.17 P/Share
|
|
Feb 29
2024
|
Reshma Rangwala EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
15,667
-4.22%
|
$15,667
$1.17 P/Share
|
|
Feb 29
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
80,470
-6.37%
|
$80,470
$1.17 P/Share
|
|
Feb 29
2024
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
21,840
-5.19%
|
$21,840
$1.17 P/Share
|
|
Feb 29
2024
|
Michael Mano SVP, General Counsel&Secretary |
SELL
Open market or private sale
|
Direct |
16,973
-5.69%
|
$16,973
$1.17 P/Share
|
|
Feb 29
2024
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
27,687
-6.4%
|
$27,687
$1.17 P/Share
|
|
Feb 28
2024
|
Richard A. Paulson President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
442,800
+25.94%
|
-
|
|
Feb 28
2024
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
198,959
+32.12%
|
-
|
|
Feb 28
2024
|
Michael Mano SVP, General Counsel&Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
147,000
+33.0%
|
-
|
|
Feb 28
2024
|
Michael Mason EVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
188,205
+30.32%
|
-
|
|
Feb 28
2024
|
Stuart Poulton EVP, Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
188,205
+34.84%
|
-
|
|
Feb 28
2024
|
Reshma Rangwala EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
198,959
+34.89%
|
-
|
|
Feb 27
2024
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
2,545
-1.03%
|
$2,545
$1.32 P/Share
|
|
Feb 15
2024
|
Stuart Poulton EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
5,847
-1.72%
|
$5,847
$1.37 P/Share
|
|
Feb 06
2024
|
Michael Mason EVP, CFO & Treasurer |
SELL
Open market or private sale
|
Direct |
4,205
-1.67%
|
$4,205
$1.59 P/Share
|
|
Feb 06
2024
|
Richard A. Paulson President and CEO |
SELL
Open market or private sale
|
Direct |
4,012
-0.49%
|
$4,012
$1.59 P/Share
|
|
Jan 24
2024
|
Sohanya Roshan Cheng EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,167
+6.01%
|
-
|
|
Jan 24
2024
|
Reshma Rangwala EVP & Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,167
+7.59%
|
-
|
|
Jan 24
2024
|
Stuart Poulton EVP, Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,333
+7.29%
|
-
|
|
Jan 24
2024
|
Michael Mano SVP, General Counsel&Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
9,167
+5.71%
|
-
|
|
Jan 24
2024
|
Michael Mason EVP, CFO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
13,333
+5.04%
|
-
|